InvestorsObserver is giving Cyteir Therapeutics Inc (CYT) an Analyst Rating Rank of 16, meaning CYT is ranked higher by analysts than 16% of stocks. The average price target for CYT is $2.666 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating CYT a Buy today. Find out what this means to you and get the rest of the rankings on CYT!